RAB1B (C-term), 166-194 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-RAB1B (C-term), 166-194 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | RAB1B (C-term), 166-194 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human (predicted reactivity: bovine, monkey, mouse, porcine, rat) |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.3 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This RAB1B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 166-194 amino acids from the C-terminal region of human RAB1B. Members of the RAB protein family, such as RAB1B, are lowmolecular mass monomeric GTPases localized on the cytoplasmicsurfaces of distinct membrane-bound organelles. RAB1B functions inthe early secretory pathway and is essential for vesicle transportbetween the endoplasmic reticulum (ER) and Golgi (Chen et al., 1997[PubMed 9030196]; Alvarez et al., 2003 [PubMed 12802079]).[suppliedby OMIM]. |
| Immunogen | n/a |
| Other Names | [Ras-related protein Rab-1B; RAB1B] |
| Gene, Accession # | [RAB1B], Gene ID: 81876, NCBI: NP_112243.1, UniProt: Q9H0U4 |
| Catalog # | MBS9203272 |
| Price | $165, $370 |
| Order / More Info | RAB1B (C-term), 166-194 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Yamayoshi, S., et al. J. Virol. 84(9):4816-4820(2010) Machner, M.P., et al. Science 318(5852):974-977(2007) Monetta, P., et al. Mol. Biol. Cell 18(7):2400-2410(2007) Wu, C., et al. Proteomics 7(11):1775-1785(2007) Ewing, R.M., et al. Mol. Syst. Biol. 3, 89 (2007) : |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies